In the ongoing battle against drug-resistant bacteria, Kinvard Bio is pioneering the creation of new antibiotics that aim to tackle one of modern medicine's most pressing issues: antimicrobial resistance.This innovative Harvard biotech startup, born from the intellect and dedication of leading scientists, is developing a new class of antibiotics designed to outsmart resistant pathogens.